Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Patent Rules May Hurt Biotech Industry; Limits Set On Certain Filings

Executive Summary

The U.S. Patent and Trademark Office is implementing new rules on patent filings that will make it tougher for biotechnology companies to protect their inventions

You may also be interested in...



Legal Brawl Over Patent Rules Creates Wide Trenches As More Groups Weigh In

The legal battle over the U.S. Patent and Trademark Office's efforts to limit certain patent filings intensified last month as various parties jumped into the fray

Legal Brawl Over Patent Rules Creates Wide Trenches As More Groups Weigh In

The legal battle over the U.S. Patent and Trademark Office's efforts to limit certain patent filings intensified last month as various parties jumped into the fray

PTO Hit With Second Lawsuit Opposing Continuation Rules As GSK Joins Fray

GlaxoSmithKline has filed suit against the Patent and Trademark Office to block new rules limiting the number of continuation applications a patent holder can file

Related Content

UsernamePublicRestriction

Register

ID1132956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel